about
Update on the Clinical Effect of Acupuncture Therapy in Patients with Gouty Arthritis: Systematic Review and Meta-AnalysisAcute and Subchronic Toxicity Study of the Median Septum of Juglans regia in Wistar RatsPatients' knowledge and beliefs concerning gout and its treatment: a population based study.Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.New and improved strategies for the treatment of goutEfficacy and safety of febuxostat in patients with hyperuricemia and gout.The prescription of allopurinol in a tertiary care centre: appropriate indications and dose adjustmentA novel enzymatic approach in the production of food with low purine content using Arxula adeninivorans endogenous and recombinant purine degradative enzymes.Managing your patient with gout: a review of treatment options.Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.Xanthine oxidase inhibitory activity of the methanolic extracts of selected Jordanian medicinal plants.Efficacy of Canakinumab vs. triamcinolone acetonide according to multiple gouty arthritis-related health outcomes measures.Allopurinol use in a New Zealand population: prevalence and adherence.Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study.Do Patient Preferences for Core Outcome Domains for Chronic Gout Studies Support the Validity of Composite Response Criteria?
P2860
Q28075602-EDC4ED3D-ADFB-4E1B-B68A-24729CF7A42BQ28468554-3131307C-804C-4338-B4C9-2B7DB0E484CAQ31096665-BCEB8AB0-DBEA-4820-B63D-80F2E10300DDQ35012174-741906CD-DE11-455D-BA24-856144842E0DQ35026692-A447D1CB-D40A-49C9-9C65-9AB0AF567D29Q36059557-E9A69A50-1E33-4E48-AC11-A2FE0B249D49Q36089063-2E347080-E13D-432D-9429-DB21C0C29F87Q36147138-DD2084A7-0F70-40E0-B45A-8ADD9A0F7F66Q37874889-C5827F0B-C789-4F24-90A6-5BAABFC211E8Q38365938-DD1C9257-F22B-4A22-A01B-0AFF974E9ADFQ40497909-AF8641A6-43FF-4E70-88F3-795E7AC78D58Q46172479-87BA2EC4-CFE2-4766-BE87-0EB790E111F2Q46181270-6D9A926F-2992-4BAC-9439-5E27A4B330C0Q46594268-1E2D2703-3B38-4C5D-BD3A-49E15E88B758Q52844811-87851ABD-8191-4C95-A310-561CC3C524D6Q56487009-6568DCDF-0EE4-4FBA-8265-E12D25DAC3AE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gout--what are the treatment options?
@en
Gout--what are the treatment options?
@nl
type
label
Gout--what are the treatment options?
@en
Gout--what are the treatment options?
@nl
prefLabel
Gout--what are the treatment options?
@en
Gout--what are the treatment options?
@nl
P2860
P1476
Gout--what are the treatment options?
@en
P2093
Naomi Schlesinger
P2860
P304
P356
10.1517/14656560902950742
P407
P577
2009-06-01T00:00:00Z